Citra-Lock™
Citra-Lock™ The safe, easy and effective way to lock every catheter
Citra-Lock™ - catheter lock solution, anti-clotting and antimicrobial is one of the innovations from Dirinco.
The Citrate lock is based on tri-sodium citrate and can be safely used in all catheters!
The Dirinco Group is a Dutch and Swiss based company, with innovations mainly in the field of vascular access, hemotology, oncology and nephrology.
- Citra-Lock™ 4% 5ml vial
- Citra-Lock™ 30% 5ml vial
- Citra-Lock™ 46,7% 5ml vial
- CitraFlow™ 4% prefilled syringe 2,5ml
Citra-Lock™ and Citra-Flow™ are registered as a medical device (Class IIb)
NEW: Citra-Lock™ in a needle-free vial
Increase safety & Simplify handling
The new Citra-Lock™ vial features a drip free Luer-slip/Luer-lock connector:
- Preventing microbial contamination
- Protecting against needle stick injuries
- Reducing handling steps
- Promoting intuitive handling
New European Guidelines Catheter Lock Solution
In the June 2010 edition of NDTplus the new European recommendation of preventing heamodialysis catheters by ERBP is published.
ERBP ( European Renal Best Practice) is the new guidance body of the European Renal Association–European Dialysis and Transplantation Association (ERA–EDTA).
The ERBP recommends to use Citrate lock of minimal 4% as the catheter lock solution instead of heparin.
'The clinical advantages offered by citrate have been confirmed in at least two meta-analyses Over time, progressively lower concentrations of citrate have been applied (from 46.7% to 4%) with still significantly better results, even in the latter case, than those obtained with heparin locks1' .
1. Vanholder et al, Diagnosis, prevention and treatment of haemodialysis catheter-related blood stream infections (CRBSI), a position statement of European Renal Best Practice (ERBP). NDTplus June 2010
New scientific evidence Citra-Lock 46,7%
The European Neprhrology published an artcile of R. Lagaac ( Cambridge University Hospitals) with the following conclusion:
The incidence of the dialyse line related infection has fallen 75% in the six months, since Trisodium citaret 46,7% was introduced compared with 6 months period prior to its introduction. Download article and advertisment of Citra-Lock.
Download artcile of R. Lagaac here >
go to page 138!
Newsletter
Subscribe to our newsletter!Please fill out the form below so we can inform when there are:
- New scientific articles with Citra-Lock™
- Exhibition & Congress dates
- New product release information
- Latest updates about Citra-lock™ guidelines
Signout from our newsletter